6th Open EBF Symposium to be held 20–22 November 2013 calls for papers.
Detecting oxidized low-density lipoprotein may be the key to identifying and monitoring patients at risk of coronary artery disease
Shiel Medical Laboratory developed the Oxidized LDL Triple Marker Test which could help to recognise and examine patients at risk of coronary artery disease.
Two major institutions join forces to change the future of life science research.
GOBIOM database is composed of 20,000 biomarkers, with updated information on all biomarkers reported in clinical and preclinical studies.
Leading global CRO, PPD, have recently announced they are doubling the number of therapeutic area heads at the company by appointing three new experts, with a view to expanding their drug development expertise.
Method comprising simple derivatization achieves accurate and precise LC–MS/MS analysis of urea.
ALMSCO to showcase latest products at Pittcon 2013.
Preterm birth risk diagnostic test to be given boost by partnership between Agilent Technologies and Sera PrognosticsPreterm birth risk diagnostic test to be given boost by partnership between Agilent Technologies and Sera Prognostics
Agilent has entered a partnership with the women’s health company to develop proteomic assays for fetal and maternal health.
Trovagene have recently announced that their urine-based HPV Carrier and oncogene mutation tests are expected to achieve analytical and clinical validation in March 2013.
New Prelude SPLC system makes LC-MS/MS analysis more user friendly.